Friday, November 12, 2004
Eliot Spitzer targets pharmaceutical industry, criticizes FDA
Eliot Spitzer is back in the news. According to Reuters—
New York Attorney General Eliot Spitzer on Friday criticized the U.S. Food and Drug Administration, and Health and Human Services Secretary Tommy Thompson, for failing to ensure that the drug industry publicly disclose negative results about its drugs.
The failure, he said, has allowed companies to suppress negative information to the detriment of patients.
Spitzer sued GlaxoSmithKline Plc
in June, charging the company with suppressing negative data about its antidepressant Paxil. The company settled the suit in August.
"The FDA's failure to jump into the issue of disclosure of clinical testing in an aggressive way is very problematic," Spitzer told the Reuters Health Summit in New York. "From day one, when we announced the Glaxo case, we have been saying, 'Where is the FDA'?"
He also criticized the failure of the U.S. Health and Human Services department to do more.
"I was surprised that Tommy Thompson at HHS didn't do something on this. It seems to me to be a no-brainer," he said.
I can't say which post Spitzer has his eye on, but you can bet it's at the federal level.
My nominee for President in 2008